Evaluation of three cytomegalovirus infection prophylactic regimens in liver transplant recipients

Transplant Proc. 1992 Aug;24(4):1466-7.
No abstract available

MeSH terms

  • Antiviral Agents / economics
  • Cytomegalovirus Infections / prevention & control*
  • Humans
  • Immunocompromised Host
  • Liver Transplantation / immunology*
  • Retrospective Studies
  • Risk Factors

Substances

  • Antiviral Agents